Personalized CRISPR therapies could soon reach thousands — here’s how

AI justification

Economically viable CRISPR therapies for rare diseases represent a significant ethical and health advancement. | The development of an economically viable approach to CRISPR therapies for rare genetic diseases is a major ethical and scientific advancement, particularly for SDG 3 (Good Health) and SDG 10 (Reduced Inequalities). However, the risk of unequal access remains a concern, especially for vulnerable populations.